Assessment of antigenemia assay for the diagnosis of cytomegalovirus gastrointestinal diseases in HIV-infected patients

AIDS Patient Care and STDs

Volumn 27, Issue 7, 2013, Pages 387-391

  Hamada, Yohei ^a   Nagata, Naoyoshi ^a   Shimbo, Takuro ^a   Igari, Toru ^a   Nakashima, Ryo ^a   Asayama, Naoki ^a   Nishimura, So ^a   Yazaki, Hirohisa ^a   Teruya, Katsuji ^a   Gatanaga, Hiroyuki ^a,b   Kikuchi, Yoshimi ^a   Akiyama, Junichi ^a   Ohmagari, Norio ^a   Uemura, Naomi ^c   Oka, Shinichi ^a,b  

^a NATIONAL CENTER FOR GLOBAL HEALTH AND MEDICINE   (Japan)

^b KUMAMOTO UNIVERSITY   (Japan)

^c National Center for Global Health and Medicine   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; MONOCLONAL ANTIBODY;

ADULT; ANTIGENEMIA ASSAY; ARTICLE; CD4 LYMPHOCYTE COUNT; CELL COUNT; CONTROLLED STUDY; CYTOMEGALOVIRUS INFECTION; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; ENDOSCOPIC BIOPSY; FEMALE; GASTROINTESTINAL BIOPSY; GASTROINTESTINAL ENDOSCOPY; GASTROINTESTINAL INFECTION; GASTROINTESTINAL SYMPTOM; GRANULOCYTE; HIGH RISK PATIENT; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HISTOPATHOLOGY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN TISSUE; IMMUNOASSAY; LIKERT SCALE; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; PROSPECTIVE STUDY; RECEIVER OPERATING CHARACTERISTIC; RECTUM HEMORRHAGE; SCREENING TEST; SENSITIVITY AND SPECIFICITY; VIRUS LOAD;

ADULT; AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANTIGENS, VIRAL; AREA UNDER CURVE; BIOPSY; CD4 LYMPHOCYTE COUNT; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; ENDOSCOPY, GASTROINTESTINAL; FEMALE; GASTROINTESTINAL DISEASES; HIV INFECTIONS; HUMANS; JAPAN; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; VIRAL LOAD;

EID: 84880093110     PISSN: 10872914     EISSN: 15577449     Source Type: Journal    
DOI: 10.1089/apc.2013.0115     Document Type: Article

References (26)

1. Goodgame RW. Gastrointestinal cytomegalovirus disease. Ann Intern Med 1993;119:924-935.
2. Baroco AL, Oldfield EC. Gastrointestinal cytomegalovirus disease in the immunocompromised patient. Curr Gastroenterol Rep 2008;10:409-416.
3. Toogood GJ, Gillespie PH, Gujral S, et al. Cytomegalovirus infection and colonic perforation in renal transplant patients. Transpl Int 1996;9:248-251.
4. Almeida N, Romaozinho JM, Amaro P, Ferreira M, Cipriano MA, Leitao MC. Fatal mid-gastrointestinal bleeding by cytomegalovirus enteritis in an immunocompetent patient. Acta Gastroenterol Belg 2009;72:245-248.
5. Frank D, Raicht RF. Intestinal perforation associated with cytomegalovirus infection in patients with acquired immune deficiency syndrome. Am J Gastroenterol 1984;79:201-205.
6. Korkmaz M, Kunefeci G, Selcuk H, et al. The role of early colonoscopy in CMV colitis of transplant recipients. Transplant Proc 2005;37:3059-3060.
7. Skiest DJ, Crosby C. CMV pp65 antigen testing is of limited utility in the diagnosis of concomitant CMV disease in HIVinfected patients in the HAART era. J Clin Virol 2003;28:203-213.
8. Podzamczer D, Ferrer E, Garcia A, et al. pp65 antigenemia as a marker of future CMV disease and mortality in HIV-infected patients. Scand J Infect Dis 1997;29:223-227.
9. Bek B, Boeckh M, Lepenies J, et al. High-level sensitivity of quantitative pp65 cytomegalovirus (CMV) antigenemia assay for diagnosis of CMV disease in AIDS patients and follow-up. J Clin Microbiol 1996;34:457-459.
10. Wattanamano P, Clayton JL, Kopicko JJ, et al. Comparison of three assays for cytomegalovirus detection in AIDS patients at risk for retinitis. J Clin Microbiol 2000;38:727-732.
11. Svedlund J, Sjodin I, Dotevall G. GSRS - A clinical rating scale for gastrointestinal symptoms in patients with irritable bowel syndrome and peptic ulcer disease. Dig Dis Sci 1988; 33:129-134.
12. Revicki DA, Wood M, Wiklund I, Crawley J. Reliability and validity of the Gastrointestinal Symptom Rating Scale in patients with gastroesophageal reflux disease. Qual Life Res 1998;7:75-83.
13. Gondo H, Minematsu T, Harada M, et al. Cytomegalovirus (CMV) antigenaemia for rapid diagnosis and monitoring of CMV-associated disease after bone marrow transplantation. Br J Haematol 1994;86:130-137.
14. Kanda Y, Mineishi S, Saito T, et al. Pre-emptive therapy against cytomegalovirus (CMV) disease guided by CMV antigenemia assay after allogeneic hematopoietic stem cell transplantation: a single-center experience in Japan. Bone Marrow Transplant 2001;27:437-444.
15. Mori T, Okamoto S, Matsuoka S, et al. Risk-adapted preemptive therapy for cytomegalovirus disease in patients undergoing allogeneic bone marrow transplantation. Bone Marrow Transplant 2000;25:765-769.
16. Rene E, Marche C, Chevalier T, et al. Cytomegalovirus colitis in patients with acquired immunodeficiency syndrome. Dig Dis Sci 1988;33:741-750.
17. Ljungman P, Griffiths P, Paya C. Definitions of cytomegalovirus infection and disease in transplant recipients. Clin Infect Dis 2002;34:1094-1097.
18. Mori T, Mori S, Kanda Y, et al. Clinical significance of cytomegalovirus (CMV) antigenemia in the prediction and diagnosis of CMV gastrointestinal disease after allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplant 2004;33:431-434.
19. Fica A, Cervera C, Perez N, et al. Immunohistochemically proven cytomegalovirus end-organ disease in solid organ transplant patients: Clinical features and usefulness of conventional diagnostic tests. Transpl Infect Dis 2007;9:203-210.
20. Jang EY, Park SY, Lee EJ, et al. Diagnostic performance of the cytomegalovirus (CMV) antigenemia assay in patients with CMV gastrointestinal disease. Clin Infect Dis 2009;48: e121-124.
21. Nagata N, Kobayakawa M, Shimbo T, et al. Diagnostic value of antigenemia assay for cytomegalovirus gastrointestinal disease in immunocompromised patients. World J Gastroenterol 2011;17:1185-1191.
22. Pannuti CS, Kallas EG, Muccioli C, et al. Cytomegalovirus antigenemia in acquired immunodeficiency syndrome patients with untreated cytomegalovirus retinitis. Am J Ophthalmol 1996;122:847-852.
23. Boivin G, Handfield J, Murray G, et al. Quantitation of cytomegalovirus (CMV) DNA in leukocytes of human immunodeficiency virus-infected subjects with and without CMV disease by using PCR and the SHARP Signal Detection System. J Clin Microbiol 1997;35:525-526.
24. Wetherill PE, Landry ML, Alcabes P, Friedland G. Use of a quantitative cytomegalovirus (CMV) antigenemia test in evaluating HIV + patients with and without CMV disease. J Acquir Immune Defic Syndr Hum Retrovirol 1996;12: 33-37.
25. Salzberger B, Franzen C, Fatkenheuer G, et al. CMVantigenemia in peripheral blood for the diagnosis of CMV disease in HIV-infected patients. J Acquir Immune Defic Syndr Hum Retrovirol 1996;11:365-369.
26. Pellegrin I, Garrigue I, Binquet C, et al. Evaluation of new quantitative assays for diagnosis and monitoring of cytomegalovirus disease in human immunodeficiency viruspositive patients. J Clin Microbiol 1999;37:3124-3132. Center Aiming at the Control of AIDS)